Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
3.46
-0.09 (-2.53%)
At close: Jun 02, 2025, 3:51 PM
3.56
2.89%
After-hours: Jun 02, 2025, 04:40 PM EDT

Company Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females.

The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers.

Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Evoke Pharma Inc.
Evoke Pharma Inc. logo
Country United States
IPO Date Sep 25, 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 3
CEO Matthew J. D'Onofrio MBA

Contact Details

Address:
420 Stevens Avenue
Solana Beach, California
United States
Website https://www.evokepharma.com

Stock Details

Ticker Symbol EVOK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001403708
CUSIP Number 30049G302
ISIN Number US30049G3020
Employer ID 20-8447886
SIC Code 2834

Key Executives

Name Position
Matthew J. D'Onofrio MBA Co-Founder, Chief Executive Officer & Director
Mark A. Kowieski CPA Chief Financial Officer, Treasurer & Secretary
Christopher Quesenberry Chief Commercial Officer - Gimoti (TM)
Dr. Marilyn R. Carlson D.M.D., M.D., RAC. Chief Medical Officer

Latest SEC Filings

Date Type Title
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 4 Filing
May 22, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G/A [Amend] Filing
May 13, 2025 10-Q Quarterly Report